Zydus receives USFDA approval for Albendazole Tablets USP
Zydus Cadila has received the final approval from the USFDA to market Albendazole Tablets USP (US RLD ALBENZA tablets), 200 mg. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad. This medication is used to treat certain tapeworm infections (such as neurocysticercosis and hydatid disease).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 15 2018 | 4:00 PM IST